(SARS-CoV) Pulmonary Infection of Mice Acute Respiratory Syndrome-Coronavirus Mechanisms of Host Defense following Severe

[1]  M. J. Kramer,et al.  Cell and virus sensitivity studies with recombinant human alpha interferons. , 1983, Journal of interferon research.

[2]  B. Glück,et al.  [Interferon sensitivity of various cell lines]. , 1986, Journal of basic microbiology.

[3]  F. Siegal,et al.  Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. , 1986, The Journal of clinical investigation.

[4]  B. McClane,et al.  Interferon pretreatment enhances the sensitivity of Vero cells to Clostridium perfringens type A enterotoxin. , 1987, Microbial pathogenesis.

[5]  N. Neilsen,et al.  Alveolar Macrophage Phagocytic Kinetics Following Pulmonary Parainfluenza‐3 Virus Infection , 1987, Journal of leukocyte biology.

[6]  M. Contigiani,et al.  Rapid vascular clearance of two strains of Junin virus in Calomys musculinus: selective macrophage clearance. , 1991, Acta virologica.

[7]  G. Karupiah,et al.  Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection , 1996, Journal of virology.

[8]  R. Folz,et al.  Coronavirus Pneumonia Following Autologous Bone Marrow Transplantation for Breast Cancer , 1999, Chest.

[9]  R. Atmar,et al.  Spectrum of Clinical Illness in Hospitalized Patients with “Common Cold” Virus Infections , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Grant.  Secondary persistent infection with hepatitis C virus: a challenge for adaptive immunity , 2002, The Lancet.

[11]  Xin Li,et al.  [Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization]. , 2003, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.

[12]  Xiao-Jun Ma,et al.  [Dynamic changes of plasma cytokine levels in patients with severe acute respiratory syndrome]. , 2003, Zhonghua nei ke za zhi.

[13]  J. Hou,et al.  [Clinical detection of polymerase gene of SARS-associated coronavirus]. , 2003, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.

[14]  R. Jiang,et al.  [Clinical analysis of SARS: 27 cases report]. , 2003, Zhonghua yi xue za zhi.

[15]  M. Diamond.  Evasion of innate and adaptive immunity by flaviviruses , 2003, Immunology and cell biology.

[16]  Jian Wang,et al.  [Detection of SARS-CoV RNA in stool samples of SARS patients by nest RT-PCR and its clinical value]. , 2003, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[17]  F. Liu,et al.  The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome. , 2003, Chinese medical journal.

[18]  John L. Sullivan,et al.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.

[19]  Malik Peiris,et al.  Aetiology: Koch's postulates fulfilled for SARS virus , 2003, Nature.

[20]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[21]  Xin Li,et al.  [Expression of the monoclonal antibody against nucleocapsid antigen of SARS-associated coronavirus in autopsy tissues from SARS patients]. , 2003, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.

[22]  Albert D. M. E. Osterhaus,et al.  SARS virus infection of cats and ferrets , 2003, Nature.

[23]  Christian Drosten,et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[24]  B. Pulendran,et al.  Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses1 , 2003, The Journal of Immunology.

[25]  Anantha Marri,et al.  B Cells and Antibody Play Critical Roles in the Immediate Defense of Disseminated Infection by West Nile Encephalitis Virus , 2003, Journal of Virology.

[26]  Y. Guan,et al.  Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage , 2003, Journal of Molecular Biology.

[27]  D. Hui,et al.  SARS: clinical features and diagnosis , 2003, Respirology.

[28]  Jiahai Lu,et al.  Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA. , 2003, Chinese medical journal.

[29]  O. Tsang,et al.  Outcomes and Prognostic Factors in 267 Patients with Severe Acute Respiratory Syndrome in Hong Kong , 2003, Annals of Internal Medicine.

[30]  K. Walley,et al.  Severe acute respiratory distress syndrome (SARS): A critical care perspective , 2003, Critical care medicine.

[31]  J. Sung,et al.  Detection of SARS Coronavirus RNA in the Cerebrospinal Fluid of a Patient with Severe Acute Respiratory Syndrome , 2003, Clinical chemistry.

[32]  Hisashi Moriguchi,et al.  Treatment of SARS with human interferons , 2003, The Lancet.

[33]  J. Collazos.  Opportunistic Infections of the CNS in Patients with AIDS , 2003, CNS drugs.

[34]  Alexander E Gorbalenya,et al.  Mechanisms and enzymes involved in SARS coronavirus genome expression. , 2003, The Journal of general virology.

[35]  Xin Li,et al.  The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.

[36]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[37]  Saurabh Menon,et al.  ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis , 2004, Journal of Biological Chemistry.

[38]  B. Moss,et al.  Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Michelle M. Packard,et al.  Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice , 2004, Journal of Virology.

[40]  Gary J. Nabel,et al.  A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice , 2004, Nature.

[41]  D. Dimitrov,et al.  A model of the ACE2 structure and function as a SARS-CoV receptor , 2003, Biochemical and Biophysical Research Communications.

[42]  Xiaolei Yin,et al.  Expression cloning of functional receptor used by SARS coronavirus , 2004, Biochemical and Biophysical Research Communications.

[43]  J. Peiris,et al.  Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids , 2004, Clinical and experimental immunology.

[44]  Ton de Jong,et al.  Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques , 2004, Nature Medicine.

[45]  J. Sung,et al.  Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome , 2004, Clinical and experimental immunology.

[46]  J. Struthers,et al.  Effect of interferon on Vero cells persistently infected with Sendai virus compared to Vero cells persistently infected with SSPE virus , 2005, Archives of Virology.